WASHINGTON, Oct. 4 (UPI) -- The U.S. Food and Drug Administration has announced a plan to increase the number of generic drug products available to consumers and healthcare providers.
PITTSBURGH, May 30 (UPI) -- U.S generic firm Mylan said Wednesday it has been granted approval to sell a high-dose generic version of Eli Lilly's Prozac.
REYKJAVIK, Iceland, Feb. 7 (UPI) -- Actavis said Wednesday the U.S. Food and Drug Administration has approved its generic version of Pfizer's Zoloft.
JERUSALEM, Aug. 4 (UPI) -- Teva said Friday it has been approved for U.S. sales of venlafaxine HCl tablets, a generic version of Wyeth's Effexor.
WOODCLIFF LAKE, N.J., Aug. 1 (UPI) -- Barr Laboratories said Tuesday the U.S. Food and Drug Administration OK'd its generic version of Pfizer's anti-panic drug Xanax XR.
JERUSALEM, June 23 (UPI) -- As cholesterol drug Zocor loses patent Friday, a battle is brewing between Teva and Novartis over the coveted generic market.
HAWTHORNE, N.Y., March 15 (UPI) -- Taro said Wednesday it has been approved to market generic Elocon Lotion, a corticosteroid to treat skin inflammation.
SPRING VALLEY, N.Y., Feb. 24 (UPI) -- Par said Friday a U.S. District Court granted GlaxoSmithKline's motion to temporarily suspend approval of generic Flonase.
SEOUL, Nov. 22 (UPI) -- Two South Korean companies have developed, separately, generic versions of the anti-flu drug Tamiflu.
WASHINGTON, Nov. 21 (UPI) -- Par Pharmaceuticals said Monday it has been approved to market a generic version of GlaxoSmithKline's Zofran.
